ArticleCancer discovery2020
Cancer Labs Pivot to Battle COVID-19.
Article in Cancer discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.Critical reviews in oncology/hematology · 2020Pooled it
- Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic.Advanced drug delivery reviews · 2022Review
- Endothelial cells and SARS-CoV-2: An intimate relationship.Vascular pharmacology · 2021Review
- Severity of COVID-19 in patients with lung cancer: evidence and challenges.Journal for immunotherapy of cancer · 2021Review
- The Deadly Duo of COVID-19 and Cancer!Frontiers in molecular biosciences · 2021Review
- Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?Pharmacogenomics · 2020Article
- The future of cancer research after COVID-19 pandemic: recession?Future oncology (London, England) · 2020Article
- Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As cancer researchers shutter their labs to comply with COVID-19-related work restrictions, some are turning their attention, resources, and technical know-how to the challenge of tackling the deadly coronavirus.
Indexed as
Identifiers
32234716What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.